From April 1, 2023 to June 30, 2023, the company has repurchased 6,879,600 shares, representing 1.21% for CNY 39.42 million. With this, the company has completed the repurchase of 14,523,100 shares, representing 2.57% for CNY 79.72 million under the buyback announced on July 15, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.07 CNY | -2.31% | -4.16% | -17.29% |
1st Jan change | Capi. | |
---|---|---|
-17.29% | 400M | |
+37.78% | 705B | |
+32.82% | 583B | |
-3.51% | 364B | |
+19.94% | 332B | |
+5.14% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+9.32% | 169B |
- Stock Market
- Equities
- 600222 Stock
- News Henan Taloph Pharmaceutical Stock Co.,Ltd
- Tranche Update on Henan Taloph Pharmaceutical Stock Co.,Ltd's Equity Buyback Plan announced on July 15, 2022.